Range
30.03 - 32.65
Vol / Avg.
551.3K/250.4K
Div / Yield
-
52 Wk
23.69 - 95.38
Mkt Cap
1.5B
Payout Ratio
-
Open
31.69
P/E
-
EPS
-0.47
Shares
47M
Outstanding
47M
Total Float
7.1M
Benzinga - May 11, 2021, 7:57AM
Benzinga - Apr 26, 2021, 11:29AM
Benzinga - Apr 26, 2021, 6:30AM
Benzinga - Mar 17, 2021, 7:39AM
Benzinga - Mar 16, 2021, 8:25AM
Benzinga - Jan 7, 2021, 5:46AM
Benzinga - Jan 4, 2021, 4:11PM
Benzinga - Dec 16, 2020, 1:05PM
Benzinga - Nov 12, 2020, 8:08AM
Benzinga - Nov 10, 2020, 7:35AM
Benzinga - Oct 20, 2020, 7:48AM
Benzinga - Oct 20, 2020, 6:41AM
Benzinga - Oct 20, 2020, 6:40AM
load more
Sector: Health Care.Industry: Biotechnology
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-07-28
REV
Q1 2021Est.ActualSurprise
EPS-0.460-0.470 -0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
PRLDPrelude Therapeutics-4.14%1.5B

Prelude Therapeutics Frequently Asked Questions

Q

How do I buy Prelude Therapeutics (PRLD) stock?

A

You can purchase shares of Prelude Therapeutics (NASDAQ: PRLD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Prelude Therapeutics's (PRLD) competitors?

A

Other companies in Prelude Therapeutics’s space includes: Replimune Group (NASDAQ:REPL), Cerevel Therapeutics Hldg (NASDAQ:CERE), Arcutis Biotherapeutics (NASDAQ:ARQT), Sangamo Therapeutics (NASDAQ:SGMO) and Constellation (NASDAQ:CNST).

Q

What is the target price for Prelude Therapeutics (PRLD) stock?

A

The latest price target for Prelude Therapeutics (NASDAQ: PRLD) was reported by HC Wainwright & Co. on April 26, 2021. The analyst firm set a price target for 62.00 expecting PRLD to rise to within 12 months (a possible 99.87% upside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Prelude Therapeutics (PRLD)?

A

The stock price for Prelude Therapeutics (NASDAQ: PRLD) is $31.02 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Prelude Therapeutics (PRLD) pay a dividend?

A

There are no upcoming dividends for Prelude Therapeutics.

Q

When is Prelude Therapeutics (NASDAQ:PRLD) reporting earnings?

A
Prelude Therapeutics’s Q2 earnings are confirmed for after-market on July 28, 2021.
Q

Is Prelude Therapeutics (PRLD) going to split?

A

There is no upcoming split for Prelude Therapeutics.

Q

What sector and industry does Prelude Therapeutics (PRLD) operate in?

A

Prelude Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.